Reinhard Hinterleitner

Reinhard Hinterleitner

Auto-generated profile, based on publicly available information

Reinhard Hinterleitner

University of Pittsburgh 1 Department of Immunology Pittsburgh, Pennsylvania

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2017 in Science
Verified
Journal Article
Closed access
PDF file
RBRomain Bouziat
Romain Bouziat
RHReinhard Hinterleitner
Reinhard Hinterleitner
JBJudy J. Brown
Judy J. Brown
JSJennifer E. Stencel-Baerenwald
Jennifer E. Stencel-Baerenwald
MIMine Ikizler
Mine Ikizler
BJBana Jabri
Bana Jabri
Viral infections have been proposed to elicit pathological processes leading to the initiation of T helper 1 (TH1) immunity against dietary gluten and celiac disease (CeD). To test this hypothesis and gain insights into mechanisms underlying virus-induced loss of tolerance to dietary antigens, we developed a viral infection model that makes use of two reovirus strains that infect the intestine but differ in their immunopathological outcomes. Reovirus is an avirulent pathogen that elicits protective immunity, but we discovered that it can nonetheless disrupt intestinal immune homeostasis at inductive and effector sites of oral tolerance by suppressing peripheral regulatory T cell (pTreg) conversion and promoting TH1 immunity to dietary antigen. Initiation of TH1 immunity to dietary antigen was dependent on interferon regulatory factor 1 and dissociated from suppression of pTreg conversion, which was mediated by type-1 interferon. Last, our study in humans supports a role for infection with reovirus, a seemingly innocuous virus, in triggering the development of CeD.

3 June 2020 in Blood Advances
Verified
Journal Article
Open access
PDF file
LBLambert Busque
Lambert Busque
MSMaxine Sun
Maxine Sun
MBManuel Buscarlet
Manuel Buscarlet
SASami Ayachi
Sami Ayachi
YZYassamin Feroz Zada
Yassamin Feroz Zada
Jean-Claude TardifJean-Claude Tardif
Jean-Claude Tardif
Clonal hematopoiesis of indeterminate potential (CHIP) is predictive of hematological cancers and cardiovascular diseases, but the etiology of CHIP initiation and clonal expansion is unknown. Several lines of evidence suggest that proinflammatory cytokines may favor mutated hematopoietic stem cell expansion. To investigate the potential link between inflammation and CHIP, we performed targeted deep sequencing of 11 genes previously implicated in CHIP in 1887 subjects aged >70 years from the Montreal Heart Institute Biobank, of which 1359 had prior coronary artery disease (CAD), and 528 controls did not. We assessed association of CHIP with log transformed high-sensitivity C-reactive protein (hs-CRP), a validated biomarker of inflammation. CHIP was identified in 427 of the 1887 subjects (22.6%). CHIP mutations were more frequently identified in DNMT3A (11.6%) and TET2 (6.1%), with a higher proportion of TET2 mutations occurring in controls than in patients with CAD (9.0% vs 4.9%, P < .001). CHIP carriers had 21% higher hs-CRP levels compared with their noncarrier counterparts (eβ = 1.21, 95% confidence interval [CI]: 1.08 to 1.36; P = .001). A similar effect was observed in the subgroup of patients with known CAD (eβ = 1.22, 95% CI: 1.06 to 1.41; P = .005). These findings confirm the association between inflammation and CHIP. This association may open investigational avenues aimed at documenting mechanisms linking inflammation to clonal progression and ultimately supports prevention interventions to attenuate CHIP’s impact on cardiovascular disease and cancer.

8 June 2018 in Science Immunology
Verified
Journal Article
Open access
PDF file
ŠKŠpela Konjar
Špela Konjar
UFUlrika C. Frising
Ulrika C. Frising
CFCristina Ferreira
Cristina Ferreira
RHReinhard Hinterleitner
Reinhard Hinterleitner
TMToufic Mayassi
Toufic Mayassi
MVMarc Veldhoen
Marc Veldhoen
The semi-activation state of IELs is maintained by an altered cardiolipin makeup of their mitochondrial membranes.

20 July 2023 in Immunity
Verified
Journal Article
Closed access
LSLuzmariel Medina Sanchez
Luzmariel Medina Sanchez
MSMagdalena Siller
Magdalena Siller
YZYanlin Zeng
Yanlin Zeng
PBPamela H. Brigleb
Pamela H. Brigleb
KSKishan A. Sangani
Kishan A. Sangani
RHReinhard Hinterleitner
Reinhard Hinterleitner

22 August 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
PBPamela H. Brigleb
Pamela H. Brigleb
EKElaine Kouame
Elaine Kouame
KFKay L. Fiske
Kay L. Fiske
GTGwen M. Taylor
Gwen M. Taylor
KUKelly Urbanek
Kelly Urbanek
TDTerence S. Dermody
Terence S. Dermody
Celiac disease is an immune-mediated intestinal disorder that results from loss of oral tolerance (LOT) to dietary gluten. Reovirus elicits inflammatory Th1 cells and suppresses Treg responses to dietary antigen in a strain-dependent manner. Strain type 1 Lang (T1L) breaks oral tolerance, while strain type 3 Dearing reassortant virus (T3D-RV) does not. We discovered that intestinal infection by T1L in mice leads to the recruitment and activation of NK cells in mesenteric lymph nodes (MLNs) in a type I IFN–dependent manner. Once activated following infection, NK cells produce type II IFN and contribute to IFN-stimulated gene expression in the MLNs, which in turn induces inflammatory DC and T cell responses. Immune depletion of NK cells impairs T1L-induced LOT to newly introduced food antigen. These studies indicate that NK cells modulate the response to dietary antigen in the presence of a viral infection.

22 July 2025 in Immunity
Verified
Journal Article
Closed access
SPSurya P. Pandey
Surya P. Pandey
DYDonghui Yang
Donghui Yang
LHLee Hedden
Lee Hedden
CLColin R. Laughlin
Colin R. Laughlin
WWWeihong Wang
Weihong Wang
RHReinhard Hinterleitner
Reinhard Hinterleitner